Cite
STAT3 inhibitor enhances chemotherapy drug efficacy by modulating mucin 1 expression in non-small cell lung carcinoma.
MLA
Yunguo Han, et al. “STAT3 Inhibitor Enhances Chemotherapy Drug Efficacy by Modulating Mucin 1 Expression in Non-Small Cell Lung Carcinoma.” Tropical Journal of Pharmaceutical Research, vol. 16, no. 7, July 2017, pp. 1513–21. EBSCOhost, https://doi.org/10.4314/tjpr.v16i7.8.
APA
Yunguo Han, Xia Lu, & Guangmin Wang. (2017). STAT3 inhibitor enhances chemotherapy drug efficacy by modulating mucin 1 expression in non-small cell lung carcinoma. Tropical Journal of Pharmaceutical Research, 16(7), 1513–1521. https://doi.org/10.4314/tjpr.v16i7.8
Chicago
Yunguo Han, Xia Lu, and Guangmin Wang. 2017. “STAT3 Inhibitor Enhances Chemotherapy Drug Efficacy by Modulating Mucin 1 Expression in Non-Small Cell Lung Carcinoma.” Tropical Journal of Pharmaceutical Research 16 (7): 1513–21. doi:10.4314/tjpr.v16i7.8.